tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Philogen Withdraws Nidlegy™ Application from EMA, Plans Resubmission
Company AnnouncementsPhilogen Withdraws Nidlegy™ Application from EMA, Plans Resubmission
2d ago
Philochem Licenses Prostate Cancer Agent to RayzeBio in $1.35 Billion Deal
PremiumCompany Announcements
Philochem Licenses Prostate Cancer Agent to RayzeBio in $1.35 Billion Deal
16d ago
Philogen Updates on Share Buyback Program
PremiumCompany Announcements
Philogen Updates on Share Buyback Program
24d ago
Philogen S.p.A. Releases Shareholders’ Meeting Minutes
PremiumCompany Announcements
Philogen S.p.A. Releases Shareholders’ Meeting Minutes
1M ago
Philogen S.p.A. Updates on Share Buyback Program
PremiumCompany Announcements
Philogen S.p.A. Updates on Share Buyback Program
1M ago
Philogen Updates Share Buyback Program with Recent Purchases
PremiumCompany AnnouncementsPhilogen Updates Share Buyback Program with Recent Purchases
1M ago
Philogen S.p.A. Updates on Share Buyback Program
Premium
Company Announcements
Philogen S.p.A. Updates on Share Buyback Program
2M ago
Philogen S.p.A. Reports Strong Financial Position and Progress in Clinical Trials
Premium
Company Announcements
Philogen S.p.A. Reports Strong Financial Position and Progress in Clinical Trials
2M ago
Philogen S.p.A. Approves 2024 Financials and Appoints New Board
PremiumCompany Announcements
Philogen S.p.A. Approves 2024 Financials and Appoints New Board
2M ago
Philogen S.p.A. Advances Share Buyback Program with Latest Acquisition
PremiumCompany Announcements
Philogen S.p.A. Advances Share Buyback Program with Latest Acquisition
2M ago
Philogen Announces Voting Rights Ahead of Shareholders’ Meeting
PremiumCompany Announcements
Philogen Announces Voting Rights Ahead of Shareholders’ Meeting
3M ago
Philogen S.p.A. Proposes New Board of Directors
PremiumCompany Announcements
Philogen S.p.A. Proposes New Board of Directors
3M ago
Philogen Updates on Share Buyback Program
PremiumCompany AnnouncementsPhilogen Updates on Share Buyback Program
3M ago
Philogen Updates Share Buyback Program, Strengthening Market Position
Premium
Company Announcements
Philogen Updates Share Buyback Program, Strengthening Market Position
3M ago
Philogen Publishes Shareholders’ Meeting Documentation for April 2025
Premium
Company Announcements
Philogen Publishes Shareholders’ Meeting Documentation for April 2025
3M ago
Philogen S.p.A. Achieves Record Profits and Advances Cancer Therapy Pipeline
PremiumCompany Announcements
Philogen S.p.A. Achieves Record Profits and Advances Cancer Therapy Pipeline
3M ago
Philogen S.p.A. Announces Shareholder Meeting to Discuss Financial and Governance Strategies
PremiumCompany Announcements
Philogen S.p.A. Announces Shareholder Meeting to Discuss Financial and Governance Strategies
3M ago
Philogen S.p.A. Updates on Share Buyback Program
PremiumCompany Announcements
Philogen S.p.A. Updates on Share Buyback Program
3M ago
Philogen Updates Share Buyback Program with Recent Purchases
PremiumCompany Announcements
Philogen Updates Share Buyback Program with Recent Purchases
4M ago
Philogen S.p.A. Updates on Share Buyback Program
PremiumCompany AnnouncementsPhilogen S.p.A. Updates on Share Buyback Program
4M ago
Philogen Advances Share Buyback Program
Premium
Company Announcements
Philogen Advances Share Buyback Program
5M ago
Philogen SpA: Strategic Partnerships and Clinical Progress Drive Buy Rating
Premium
Ratings
Philogen SpA: Strategic Partnerships and Clinical Progress Drive Buy Rating
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >